The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
about
Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based TherapyAdoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis.Type 1 diabetes immunotherapy using polyclonal regulatory T cellsTherapeutic immune monitoring of CD4+CD25+ T cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.Challenges and opportunities in the manufacture and expansion of cells for therapy.Decreased Circulating T Regulatory Cells in Egyptian Patients with Nonsegmental Vitiligo: Correlation with Disease Activity.Targeting of tolerogenic dendritic cells towards heat shock proteins: a novel therapeutic strategy for autoimmune diseases?Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatmentTargeting the epitope spreader Pep19 by naïve human CD45RA+ regulatory T cells dictates a distinct suppressive T cell fate in a novel form of immunotherapy.IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells.Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.Regulation of Effector Treg Cells in Murine Lupus.Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.Intradermal injection of low dose human regulatory T cells inhibits skin inflammation in a humanized mouse model.Regulatory T cells in embryo implantation and the immune response to pregnancyThe transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cellsTherapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
P2860
Q26774657-CF0BEC61-0EE3-4B3A-ADE4-5FCCE76DC07EQ33862280-C7D35B6F-0285-4A2E-A9F9-FF2F4806244BQ36509805-885D68D5-D179-4168-A842-5FD681F5294CQ38624811-53481A41-AD13-4933-BD70-85D82C4F83B7Q38646797-7AC174D3-91FB-4DD0-8A76-828A3E38D3BFQ38918556-2F4D430D-C7BD-41E3-ADCF-922FFC57701BQ40095092-2041FCF6-99CD-419F-BAD9-D5A43025D859Q41004126-F7A84D21-CF95-4F21-B16A-0F750232FC68Q46184995-17F4981F-DEEC-4AB4-90AB-B6306A6A52E6Q48130514-34B41252-D6E6-4805-9633-B226F9CE959BQ49884887-DE4C5684-2333-4782-A3C7-65D976FCFD7DQ50306049-1E9F787A-25EF-4C50-9E04-24661EFEC909Q51095965-2521CCC1-C390-4D02-AFEF-5CFDCBFC07F7Q55667006-F784E918-925A-4462-BD71-38189CA2E04EQ57057008-00F16A7B-0DC6-42C8-9393-5D9B67EDE8BCQ58115470-5E7A051F-85F8-4F90-8B92-5B756EB882C1Q58773667-56B964AD-9FEA-4597-B2FF-BD43663A8B08
P2860
The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
@en
type
label
The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
@en
prefLabel
The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
@en
P2093
P2860
P1476
The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
@en
P2093
Eleonora Trotta
Jeffrey A Bluestone
P2860
P304
P356
10.1517/14728222.2015.1037282
P407
P577
2015-04-16T00:00:00Z